l 734217 has been researched along with beta-alanine in 4 studies
*beta-Alanine: An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. [MeSH]
*beta-Alanine: An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported. [MeSH]
| Studies (l 734217) | Trials (l 734217) | Recent Studies (post-2010) (l 734217) | Studies (beta-alanine) | Trials (beta-alanine) | Recent Studies (post-2010) (beta-alanine) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 3,177 | 207 | 1,807 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, PS; Chang, CT; Cook, JJ; Duggan, ME; Gould, RJ; Hartman, GD; Ihle, NC; Lynch, JJ; Naylor-Olsen, AM; Perkins, JJ | 1 |
| Cook, JJ; Drag, MD; Duggan, ME; Gehret, JR; Gould, RJ; Hand, EL; Hartman, GD; Holahan, MA; Ihle, NC; Kothstein, T; Lyle, EA; Lynch, JJ; McCormick, GY; Perkins, JJ; Ramjit, DR; Sitko, GR; Stranieri, MT; Stupienski, RF; Wallace, AA | 1 |
| Cook, JJ; Ellis, JD; Hand, EL; Holahan, MA; Prueksaritanont, T; Sitko, GR; Stranieri, MT | 1 |
| Bednar, B; Bednar, RA; Cook, JJ; Cunningham, ME; Gould, RJ; Hartman, GD; Holahan, MA; Jumes, PA | 1 |
4 other study(ies) available for l 734217 and beta-alanine
| Article | Year |
|---|---|
Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonist.
Topics: Administration, Oral; Amino Acid Sequence; Animals; beta-Alanine; Cells, Cultured; Dogs; Drug Design; Humans; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Pan troglodytes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins | 1995 |
Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.
Topics: Animals; beta-Alanine; Dogs; Dose-Response Relationship, Drug; Glycoproteins; Guinea Pigs; Male; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley | 1996 |
Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734,217, in dogs.
Topics: Adenosine Diphosphate; Adjuvants, Anesthesia; Animals; Area Under Curve; beta-Alanine; Collagen; Cross-Over Studies; Dogs; Dose-Response Relationship, Drug; Half-Life; Injections, Intravenous; Male; Pentobarbital; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Radioimmunoassay | 1997 |
Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Azepines; beta-Alanine; Blood Platelets; Disease Susceptibility; Dogs; Epitopes; Female; Fibrinolytic Agents; Humans; Immunoglobulin G; Macaca mulatta; Macromolecular Substances; Male; Molecular Structure; Oligopeptides; Pan troglodytes; Piperazines; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Primates; Protein Binding; Sulfonamides; Thrombocytopenia | 1999 |